Hera Med Ltd
ASX:HMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Hera Med Ltd
Research & Development
Hera Med Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Hera Med Ltd
ASX:HMD
|
Research & Development
-$1m
|
CAGR 3-Years
1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
B
|
Brainsway Ltd
TASE:BWAY
|
Research & Development
-$9.1m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-7%
|
|
|
Inmode Ltd
NASDAQ:INMD
|
Research & Development
-$13.3m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
Sisram Medical Ltd
HKEX:1696
|
Research & Development
-$16.9m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
A
|
Alpha Tau Medical Ltd
NASDAQ:DRTS
|
Research & Development
-$32.1m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sofwave Medical Ltd
TASE:SOFW
|
Research & Development
-$10.4m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Hera Med Ltd
Glance View
HeraMED Ltd. engages in the development and production of pregnancy monitoring solutions for home and professional use. The company offers hardware solutions supported by software applications. Its product HeraBEAT, is a medical-grade, clinically-validated and connected Ultrasound Fetal Doppler device predominantly for use by an expectant mother to self-monitor her fetus’ heart rate (FHR) at home. HeraBEAT communicates with any smartphone (iOS/Android) through Bluetooth Low Energy (BLE). A mother can hold or strap the HeraBEAT device to her abdomen, and the collected data is transmitted to her smartphone where the relevant readings are displayed through an interface. The firm also develops a service model which includes a homecare pregnancy solution. In addition, the Company develops artificial intelligence (AI), machine-learning, computerized algorithms to monitor and analyze the data so a healthcare professional or home user is informed of the wellbeing of the fetus.
See Also
What is Hera Med Ltd's Research & Development?
Research & Development
-1m
USD
Based on the financial report for Dec 31, 2025, Hera Med Ltd's Research & Development amounts to -1m USD.
What is Hera Med Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
3%
Over the last year, the Research & Development growth was 23%. The average annual Research & Development growth rates for Hera Med Ltd have been 1% over the past three years , 3% over the past five years .
